| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 744650 | Null | 0.0430277102950697 | 0.48870452 |
| NSC 746035 | 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone | 0.0430277102950697 | 0.32620656 |
| NSC 749117 | 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline | 0.0430277102950697 | 0.34926677 |
| NSC 752461 | Null | 0.0430277102950697 | 0.52391441 |
| NSC 757946 | (1R,2E,6R,10E,11aS,13S,14aR)-1,13-dihydroxy-6-(2-hydroxyethyl)-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one | 0.0430277102950697 | -0.25438608 |
| NSC 100290 | Doxypyrromycin hydrochloride | 0.04302771029507 | 0.47510314 |
| NSC 111702 | p-Dioxane-2-methanol, 3,5-dihydroxy-6-[6-(methylthio)-9H-purin-9-yl]- | 0.04302771029507 | 0.394591 |
| NSC 113237 | Null | 0.04302771029507 | 0.66778396 |
| NSC 133072 | Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) | 0.04302771029507 | 0.43454139 |
| NSC 134754 | Null | 0.04302771029507 | 0.51297665 |